Notably, circulating GDF-15 has been reported to be higher in advanced fibrosis, lower in NASH and even lower in hepatic steatosis, thus being suggested as a promising predictor of hepatic fibrosis in human NAFLD [204, 205]. This evidence concerns the gene GDF15 and metabolic dysfunction-associated steatotic liver disease.